What the analyst said

Stifel analyst Brian Chin raised the price target on Lam Research (NASDAQ: LRCX) to $300.00 (from $280.00) while maintaining a Buy rating.

“Our company-specific estimate (and corresponding price target) increases highlight names (LRCX, ICHR) we believe have higher exposure/responsiveness to recent sources of WFE upside, which should be somewhat apparent this earnings season, though moreso by 2H26.Overall, we remain upbeat on sector fundamentals; this is not as great as it gets for semicap.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LRCX trades at $185. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $300 target is 14% below the median.

Since the note LRCX has moved −30% (from $264). 12-month window: day 206 of 365, closes on April 13, 2027.

Track record

This call✓ Target reached on May 21, 2026, 38 days after the note.

Firm track recordStifel: 83% of its 42 targets at least a year old were reached within 12 months (#6 of 26 firms). Accuracy ranking →

Stifel on Lam Research

Stifel price targets on Lam Research

5 calls from January 14, 2026 to July 10, 2026. The target went from $250 to $425 (+70%). The rating stayed Buy.

Stifel targetLRCX share price
  1. July 10, 2026Target raised from $325 (+31%)Buy$425
  2. April 23, 2026Target raised from $300 (+8%)Buy$325
  3. April 13, 2026 This noteTarget raised from $280 (+7%)Buy$300
  4. January 29, 2026Target raised from $250 (+12%)Buy$280
  5. January 14, 2026Earliest call shownBuy$250
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.